Neurocrine Biosciences (NBIX) Stock Forecast

Analyst ratings, price targets, and earnings estimates.

NBIX Analyst Ratings

Buy

Consensus

Strong Buy
0
Buy
29
Hold
5
Sell
0
Strong Sell
0
85%15%

Based on 34 analysts in the past 3 months

NBIX Stock 12 Month Forecast

$159.00

▲ (48.97% Upside)
Highest Price Target
$192.00 (79.9%)
Average Price Target
$159.00 (49.0%)
Lowest Price Target
$121.00 (13.4%)

Based on 2 analysts in the last 3 months

Recent Price Targets
200200150150100100505000Price Target ($)Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25
Recommendation Trends
Strong Buy
Buy
Hold
Sell
Strong Sell
2828212114147700887666151515151515444555Nov 1, 2024Nov 1, 2024Dec 1, 2024Dec 1, 2024Jan 1, 2025Jan 1, 2025Feb 1, 2025Feb 1, 2025Mar 1, 2025Mar 1, 2025Apr 1, 2025Apr 1, 2025
Analyst Estimates
Revenue Estimates
High $2.71B
Average $2.65B
Low $2.46B
18 analysts
Net Income Estimates
High $495.10M
Average $402.69M
Low $306.58M
18 analysts
EPS Estimates
High $4.77
Average $4.04
Low $2.96
14 analysts
Revenue Estimates
High $3.27B
Average $3.07B
Low $2.83B
20 analysts
Net Income Estimates
High $742.60M
Average $626.91M
Low $527.17M
20 analysts
EPS Estimates
High $7.16
Average $6.07
Low $5.08
14 analysts
Revenue Estimates
High $3.51B
Average $3.50B
Low $3.48B
15 analysts
Net Income Estimates
High $1.24B
Average $895.00M
Low $322.41M
15 analysts
EPS Estimates
High $11.95
Average $8.67
Low $3.11
13 analysts
Revenue Estimates
High $4.09B
Average $3.94B
Low $3.70B
6 analysts
Net Income Estimates
High $1.20B
Average $1.14B
Low $1.05B
6 analysts
EPS Estimates
High $11.56
Average $11.02
Low $10.15
9 analysts
Revenue Estimates
High $4.29B
Average $4.13B
Low $3.88B
11 analysts
Net Income Estimates
High $1.30B
Average $1.24B
Low $1.14B
11 analysts
EPS Estimates
High $12.53
Average $11.94
Low $11.01
11 analysts
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Apr 22, 2025 Andrew Fein H.C. Wainwright $168.00 $101.74 65.1%
Mar 07, 2025 Morgan Stanley $150.00 $113.04 32.7%
Jan 08, 2025 Ashwani Verma UBS $162.00 $137.55 17.8%
Oct 31, 2024 Evan David Seigerman BMO Capital $121.00 $120.27 0.6%
Oct 22, 2024 Jay Olson Oppenheimer $192.00 $116.57 64.7%
Oct 10, 2024 Danielle Brill Raymond James $155.00 $111.62 38.9%
Sep 13, 2024 Evan David Seigerman BMO Capital $128.00 $122.29 4.7%
Sep 09, 2024 Carter Gould Barclays $160.00 $120.17 33.1%
Aug 29, 2024 Brian Abrahams RBC Capital $136.00 $123.76 9.9%
Aug 29, 2024 David Amsellem Piper Sandler $159.00 $128.43 23.8%

Related Metrics

Explore detailed financial metrics and analysis for NBIX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio